Home Newsfeeds Credit Suisse Maintains Underperform on Babcock & Wilcox, Lowers Price Target to $5

Credit Suisse Maintains Underperform on Babcock & Wilcox, Lowers Price Target to $5

Credit Suisse analyst Jamie Cook maintains Babcock & Wilcox (NYSE:BW) with a Underperform and lowers the price target from $6.5 to $5.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Credit Suisse analyst Jamie Cook maintains Babcock & Wilcox (NYSE:BW) with a Underperform and lowers the price target from $6.5 to $5.

Clean Energy Technologies Reports Q3 2023 Financial Results And Provides Business Update; For The 9-Months Ended September 30, 2023, Revenues Of $11.7M Represent An Increase Of 339% Compared To $2.6M YoY

By Benzinga Newsdesk

November 28, 9:38 AM

The company experienced sustained strong revenue growth, consistently surpassing quarterly expectations for the last three quarters.Financial and corporate highlights for the nine months ended September 30th, 2023,

CETY

Autolus Therapeutics Announces Publication In Cancer Immunology Research

By Happy Mohamed

June 27, 8:14 AM

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a publication in Cancer Immunology

AUTL

Around $1M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Buying

By Avi Kapoor

April 10, 8:35 AM

The Dow Jones index closed slightly lower on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

FLGC